サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1446913

ニュートリゲノミクス市場：製品タイプ別、用途別、エンドユーザー別：世界の機会分析と産業予測、2023-2032年

Nutrigenomics Market By Product Type, By Applications, By End User : Global Opportunity Analysis and Industry Forecast, 2023-2032
出版日: | 発行: Allied Market Research | ページ情報: 英文 280 Pages | 納期: 2～3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
ニュートリゲノミクス市場：製品タイプ別、用途別、エンドユーザー別：世界の機会分析と産業予測、2023-2032年
出版日: 2024年01月30日
発行: Allied Market Research
ページ情報: 英文 280 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ニュートリゲノミクスは、特定の遺伝子変異や多型の存在を研究するもので、ほとんどの場合、特定の疾患プロセスに対する素因を意味するだけであり、個人に合わせた栄養摂取など、環境や行動因子の複雑な相互作用によって予防できる可能性があります。

ニュートリゲノミクスとは、特定の栄養素や栄養補助食品が個人の遺伝的体質の発現に及ぼす影響を研究することです。

Nutrigenomics Market-IMG1

肥満、糖尿病、心血管疾患などの慢性疾患の有病率の上昇が、ニュートリゲノミクス検査市場の成長を促進しています。過去10年間で、プロテオミクス、ゲノミクス、メタボロミクスなどのオーミック技術が急速に進歩し、高度なバイオインフォマティクスと組み合わされて、タンパク質経路に基づく疾患の特定に広く利用されるようになっています。現在、ニュートリゲノミクスの知見は、糖尿病、がん、肥満のような食事の要素を含む疾患の治療にある程度利用されており、ニュートリゲノミクス検査市場規模を大幅に押し上げています。

ニュートリゲノミクス検査結果の正確性と信頼性は、消費者の多くにとって主要な懸念事項の1つです。ニュートリゲノミクス検査を含む消費者向け直接検査には、その主張を裏付けるさまざまなレベルの証拠があります。消費者向け直接検査には、検査で提供される情報を裏付ける科学的・臨床的データが多いものもあれば、裏付けるデータがそれほど多くないものもあります。さらに、様々な遺伝子変異が疾患に寄与している役割について臨床界で意見の相違があることも、検査の正確性と信頼性に影響を与える理由です。さらに、すべてのバリアントが個人の病気や状態になるリスクに寄与しているわけではないので、結果が陰性であっても、その人が特定の病気や状態になるリスクから解放されるわけではないことを顧客が理解することが重要です。異なる会社が異なるバリアントを検査するため、同じニュートリゲノミクス検査でも、同じ疾患について異なる結果が得られる可能性があります。従って、ニュートリゲノミクス検査の注文や結果の解釈は、顧客自身の判断で行う必要があります。したがって、ニュートリゲノミクスの検査結果は正確で信頼できるものとはみなされず、全体的な需要をさらに妨げています。

スポーツニュートリゲノミクスは、ニュートリゲノミクス検査市場にとってもう一つの重要な機会です。したがって、アスリートは健康状態を改善するためにオーダーメイドの食事を求めています。アスリート集団における個別化栄養学は、個人の遺伝子プロファイルに食事勧告の照準を合わせることにより、健康、体組成、運動パフォーマンスを最適化することを目的としています。スポーツ栄養士や管理栄養士は、様々なスポーツ人口に対応するために、一般的な食事ガイドラインに付加的な分析を加えることに長らく長けてきました。しかし、一般的な「画一的な」推奨はまだ残っています。遺伝子の違いは、栄養素や食品生物活性物質の吸収、代謝、取り込み、利用、排泄に影響を与えることが知られており、最終的には多くの代謝経路に影響を与えます。ニュートリゲノミクスとニュートリゲネティクスは、ゲノム情報と遺伝子検査技術を用いた実験的アプローチであり、栄養素やその他の食品成分に対するアスリートの反応を変化させる上で、個人の遺伝的差異が果たす役割を検討するものです。エルゴジェニック補助食品に反応するパフォーマンスに対する遺伝的変異の影響を調べるランダム化比較試験はほとんど行われていないが、運動やスポーツのパフォーマンスに影響を与える栄養状態のバイオマーカーに関する遺伝子と食事の相互作用に関連する研究の基盤は大きくなりつつあります。この基盤は、スポーツニュートリゲノミクスの分野が発展し続ける基礎を形成しています。

COVID-19パンデミックはニュートリゲノミクス検査市場の成長に大きな影響を与えました。このパンデミックは、遠隔医療に多くの新規ユーザーを導入し、潜在的な競合他社に対するその利点をさらに強化しました。また、COVID-19の大流行は、ニュートリゲノミクス市場内のさらなる業界再編やコラボレーションを推進しました。さらに、COVID-19の大流行と、その結果もたらされた消費者の行動と期待の変化は、さまざまな従来のヘルスケア・プロバイダーに、対面能力と組み合わせることができる遠隔医療の選択肢を評価し、追求させることにもなった。また、遠隔医療に対する認識、受容、利用はCOVID-19の大流行によって良い影響を受け、バーチャルケアに対する消費者の受容が高まった。このように、パンデミックは遠隔医療サービスの利用増加につながっており、パンデミック後の期間にニュートリゲノミクス市場を押し上げると予測されています。

銀行のサイバーセキュリティ市場で事業を展開している企業には、Ancestry、Nutrigenomix、23andMe Inc.、DNAfit、GX Sciences Inc.、Xcode Life、Koninklijke DSM N.V.（ロイヤルDSM）、BASF SE、Danone S.A.、The Gene Boxなどがあります。

利害関係者にとっての主なメリット

  • 当レポートでは、2022年から2032年までのニュートリゲノミクス市場分析の市場セグメント、現在の動向、推定動向、力学を定量的に分析し、一般的なニュートリゲノミクス市場機会を特定します。
  • 市場促進要因、市場抑制要因、市場機会に関連する情報とともに市場調査を提供します。
  • ポーターのファイブフォース分析では、利害関係者が利益重視のビジネス決定を下し、サプライヤーとバイヤーのネットワークを強化できるよう、バイヤーとサプライヤーの潜在力を明らかにします。
  • ニュートリゲノミクスの市場セグメンテーションの詳細な分析は、市場機会を決定するのに役立ちます。
  • 各地域の主要国は、世界市場への収益貢献度に応じてマッピングされています。
  • 市場プレイヤーのポジショニングは、ベンチマーキングを容易にし、市場プレイヤーの現在のポジションの明確な理解を提供します。
  • 地域別および世界のニュートリゲノミクス市場動向、主要企業、市場セグメント、用途分野、市場成長戦略などの分析を含みます。

本レポートで可能なカスタマイズ

  • 消費者の購買行動分析
  • エンドユーザーの嗜好とペインポイント
  • 投資機会
  • 地域別新規参入企業
  • 技術動向分析
  • 市場参入戦略
  • 製品/セグメント別の市場セグメンテーション
  • ペインポイント分析
  • 規制ガイドライン
  • 戦略的提言
  • 顧客の関心に特化した追加企業プロファイル
  • 国別または地域別の追加分析-市場規模と予測
  • クリスクロス・セグメント分析-市場規模と予測
  • 企業プロファイルの拡張リスト
  • 過去の市場データ
  • 世界/地域/国別レベルでのプレーヤーの市場シェア分析
  • SWOT分析

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

  • 市場の定義と範囲
  • 主な調査結果
    • 影響要因
    • 主な投資機会
  • ポーターのファイブフォース分析
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
  • 市場シェア分析
  • ブランドシェア分析
  • バリューチェーン分析
  • 規制ガイドライン
  • 主要規制分析

第4章 ニュートリゲノミクス市場：製品タイプ別

  • 概要
  • 試薬とキット
  • サービス

第5章 ニュートリゲノミクス市場、用途別

  • 概要
  • 肥満症
  • 糖尿病
  • 心血管疾患
  • がん研究

第6章 ニュートリゲノミクス市場：エンドユーザー別

  • 概要
  • オンラインプラットフォーム
  • 病院と診療所
  • その他

第7章 ニュートリゲノミクス市場：地域別

  • 概要
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • その他
  • ラテンアメリカ・中東・アフリカ
    • ブラジル
    • UAE
    • サウジアラビア
    • 南アフリカ
    • その他

第8章 競争情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10社の製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • 主要企業のポジショニング、2022年

第9章 企業プロファイル

  • Cura Integrative Medicine
  • Holistic Health
  • Metagenics, Inc.
  • GX Sciences Inc.
  • The Gene Box
  • Nutrigenomix Inc.
  • Xcode Life
  • DNA Life
  • Interleukin Genetics
  • Genova Diagnostics
図表

LIST OF TABLES

  • TABLE 01. GLOBAL NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 02. NUTRIGENOMICS MARKET FOR REAGENTS AND KITS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 03. NUTRIGENOMICS MARKET FOR SERVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 04. GLOBAL NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 05. NUTRIGENOMICS MARKET FOR OBESITY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 06. NUTRIGENOMICS MARKET FOR DIABETES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 07. NUTRIGENOMICS MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 08. NUTRIGENOMICS MARKET FOR CANCER RESEARCH, BY REGION, 2022-2032 ($MILLION)
  • TABLE 09. GLOBAL NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 10. NUTRIGENOMICS MARKET FOR ONLINE PLATFORMS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. NUTRIGENOMICS MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. NUTRIGENOMICS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. NUTRIGENOMICS MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. NORTH AMERICA NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 15. NORTH AMERICA NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 16. NORTH AMERICA NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 17. NORTH AMERICA NUTRIGENOMICS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 18. U.S. NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 19. U.S. NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 20. U.S. NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 21. CANADA NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 22. CANADA NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 23. CANADA NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 24. MEXICO NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 25. MEXICO NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 26. MEXICO NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 27. EUROPE NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 28. EUROPE NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 29. EUROPE NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 30. EUROPE NUTRIGENOMICS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 31. GERMANY NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 32. GERMANY NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 33. GERMANY NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 34. UK NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 35. UK NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 36. UK NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 37. FRANCE NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 38. FRANCE NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 39. FRANCE NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 40. SPAIN NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 41. SPAIN NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 42. SPAIN NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 43. ITALY NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 44. ITALY NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 45. ITALY NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 46. REST OF EUROPE NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 47. REST OF EUROPE NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 48. REST OF EUROPE NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 49. ASIA-PACIFIC NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 50. ASIA-PACIFIC NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 51. ASIA-PACIFIC NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 52. ASIA-PACIFIC NUTRIGENOMICS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 53. CHINA NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 54. CHINA NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 55. CHINA NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 56. JAPAN NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 57. JAPAN NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 58. JAPAN NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 59. INDIA NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 60. INDIA NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 61. INDIA NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 62. SOUTH KOREA NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 63. SOUTH KOREA NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 64. SOUTH KOREA NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 65. AUSTRALIA NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 66. AUSTRALIA NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 67. AUSTRALIA NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 68. REST OF ASIA-PACIFIC NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 69. REST OF ASIA-PACIFIC NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 70. REST OF ASIA-PACIFIC NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 71. LAMEA NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 72. LAMEA NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 73. LAMEA NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 74. LAMEA NUTRIGENOMICS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 75. BRAZIL NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 76. BRAZIL NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 77. BRAZIL NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 78. UAE NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 79. UAE NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 80. UAE NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 81. SAUDI ARABIA NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 82. SAUDI ARABIA NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 83. SAUDI ARABIA NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 84. SOUTH AFRICA NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 85. SOUTH AFRICA NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 86. SOUTH AFRICA NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 87. REST OF LAMEA NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 88. REST OF LAMEA NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 89. REST OF LAMEA NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 90. CURA INTEGRATIVE MEDICINE: KEY EXECUTIVES
  • TABLE 91. CURA INTEGRATIVE MEDICINE: COMPANY SNAPSHOT
  • TABLE 92. HOLISTIC HEALTH: KEY EXECUTIVES
  • TABLE 93. HOLISTIC HEALTH: COMPANY SNAPSHOT
  • TABLE 94. METAGENICS, INC.: KEY EXECUTIVES
  • TABLE 95. METAGENICS, INC.: COMPANY SNAPSHOT
  • TABLE 96. GX SCIENCES INC.: KEY EXECUTIVES
  • TABLE 97. GX SCIENCES INC.: COMPANY SNAPSHOT
  • TABLE 98. THE GENE BOX: KEY EXECUTIVES
  • TABLE 99. THE GENE BOX: COMPANY SNAPSHOT
  • TABLE 100. NUTRIGENOMIX INC.: KEY EXECUTIVES
  • TABLE 101. NUTRIGENOMIX INC.: COMPANY SNAPSHOT
  • TABLE 102. XCODE LIFE: KEY EXECUTIVES
  • TABLE 103. XCODE LIFE: COMPANY SNAPSHOT
  • TABLE 104. DNA LIFE: KEY EXECUTIVES
  • TABLE 105. DNA LIFE: COMPANY SNAPSHOT
  • TABLE 106. INTERLEUKIN GENETICS: KEY EXECUTIVES
  • TABLE 107. INTERLEUKIN GENETICS: COMPANY SNAPSHOT
  • TABLE 108. GENOVA DIAGNOSTICS: KEY EXECUTIVES
  • TABLE 109. GENOVA DIAGNOSTICS: COMPANY SNAPSHOT

LIST OF FIGURES

  • FIGURE 01. NUTRIGENOMICS MARKET, 2022-2032
  • FIGURE 02. SEGMENTATION OF NUTRIGENOMICS MARKET,2022-2032
  • FIGURE 03. TOP IMPACTING FACTORS IN NUTRIGENOMICS MARKET
  • FIGURE 04. TOP INVESTMENT POCKETS IN NUTRIGENOMICS MARKET (2023-2032)
  • FIGURE 05. BARGAINING POWER OF SUPPLIERS
  • FIGURE 06. BARGAINING POWER OF BUYERS
  • FIGURE 07. THREAT OF SUBSTITUTION
  • FIGURE 08. THREAT OF SUBSTITUTION
  • FIGURE 09. COMPETITIVE RIVALRY
  • FIGURE 10. GLOBAL NUTRIGENOMICS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 11. REGULATORY GUIDELINES: NUTRIGENOMICS MARKET
  • FIGURE 12. IMPACT OF KEY REGULATION: NUTRIGENOMICS MARKET
  • FIGURE 13. NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022 AND 2032(%)
  • FIGURE 14. COMPARATIVE SHARE ANALYSIS OF NUTRIGENOMICS MARKET FOR REAGENTS AND KITS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF NUTRIGENOMICS MARKET FOR SERVICES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 16. NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022 AND 2032(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF NUTRIGENOMICS MARKET FOR OBESITY, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF NUTRIGENOMICS MARKET FOR DIABETES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS OF NUTRIGENOMICS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF NUTRIGENOMICS MARKET FOR CANCER RESEARCH, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 21. NUTRIGENOMICS MARKET, BY END USER, 2022 AND 2032(%)
  • FIGURE 22. COMPARATIVE SHARE ANALYSIS OF NUTRIGENOMICS MARKET FOR ONLINE PLATFORMS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 23. COMPARATIVE SHARE ANALYSIS OF NUTRIGENOMICS MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 24. COMPARATIVE SHARE ANALYSIS OF NUTRIGENOMICS MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 25. NUTRIGENOMICS MARKET BY REGION, 2022 AND 2032(%)
  • FIGURE 26. U.S. NUTRIGENOMICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 27. CANADA NUTRIGENOMICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 28. MEXICO NUTRIGENOMICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 29. GERMANY NUTRIGENOMICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 30. UK NUTRIGENOMICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 31. FRANCE NUTRIGENOMICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 32. SPAIN NUTRIGENOMICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 33. ITALY NUTRIGENOMICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 34. REST OF EUROPE NUTRIGENOMICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 35. CHINA NUTRIGENOMICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 36. JAPAN NUTRIGENOMICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 37. INDIA NUTRIGENOMICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 38. SOUTH KOREA NUTRIGENOMICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 39. AUSTRALIA NUTRIGENOMICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 40. REST OF ASIA-PACIFIC NUTRIGENOMICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 41. BRAZIL NUTRIGENOMICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 42. UAE NUTRIGENOMICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 43. SAUDI ARABIA NUTRIGENOMICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 44. SOUTH AFRICA NUTRIGENOMICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 45. REST OF LAMEA NUTRIGENOMICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 46. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 47. COMPETITIVE DASHBOARD
  • FIGURE 48. COMPETITIVE HEATMAP: NUTRIGENOMICS MARKET
  • FIGURE 49. TOP PLAYER POSITIONING, 2022
目次
Product Code: A129082

Nutrigenetics studies the presence of a particular gene variant or polymorphism that in most cases merely connotes a predisposition to a particular disease process that may be prevented through a complex interplay of environmental and behavioral factors such as a personalized nutrition. Nutrigenomics refers to the study of the effects of specific nutrients or nutraceuticals on the expression of an individual's genetic makeup.

Nutrigenomics Market - IMG1

Rising prevalence of chronic diseases such as obesity, diabetes, and cardiovascular diseases is driving the growth of the nutrigenomics testing market. Over the past decade, rapid advancements in omic technologies such as proteomics, genomics, and metabolomics are combining with advanced bioinformatics to be broadly used for identifying diseases based on protein pathways. Currently, the findings of nutrigenomics have been used to some extent to treat diseases with a diet component like diabetes, cancer, and obesity, significantly boosting the nutrigenomics testing market size.

Accuracy and reliability of the nutrigenomic test findings is one of the major concerns for most of the consumers. Direct-to-consumer tests including nutrigenomic tests have varying levels of evidence that support their claims. Some direct-to-consumer tests have more scientific and clinical data to support the information provided in the test, while other tests do not have as much supporting data. Furthermore, disagreements in the clinical community about the role that different genetic variants are contributing to the disease is another reason affecting the accuracy and reliability of the test. Moreover, not all variants contribute to an individual's risk of getting a disease or condition, so it is important that customers understand that a negative result does not mean that the individual is free from the risk of developing a particular disease or condition. As different companies test for the different set of variants, therefore the same nutrigenomics tests might provide different results for the same disease. Thus, customers need to use their own judgment while ordering and interpreting the results from nutrigenomic tests. Therefore, nutrigenomics test results are not considered as accurate and reliable, further hampering the overall demand.

Sport nutrigenomics is another significant opportunity for nutrigenomics testing market. Thus, athletes are looking for tailor-made diets for improving their health status. Personalized nutrition in athletic populations aims in optimizing health, body composition, and exercise performance by targeting dietary recommendations to an individual's genetic profile. Sport dietitians and nutritionists have long been skilled at placing additional analysis on the one-size-fits-all general population dietary guidelines to accommodate various sporting populations. However, generic 'one-size-fits-all' recommendations still remain. Genetic differences are known to impact absorption, metabolism, uptake, utilization, and excretion of nutrients and food bio actives, which ultimately affects a number of metabolic pathways. Nutrigenomics and nutrigenetics are experimental approaches that use genomic information and genetic testing technologies to examine the role of individual genetic differences in modifying an athlete's response to nutrients and other food components. Although there have been few randomized, controlled trials examining the effects of genetic variation on performance in response to an ergogenic aid, there is a growing foundation of research linking gene-diet interactions on biomarkers of nutritional status, which impact exercise and sport performance. This foundation forms the basis from which the field of sport nutrigenomics continues to develop.

The COVID-19 pandemic had significant impacts on the nutrigenomics testing market growth. The pandemic introduced many new users to telehealth and further reinforced its benefits to potential competitors. In turn, the COVID-19 pandemic has also driven additional industry consolidation or collaboration within the nutrigenomics market. Furthermore, the COVID-19 pandemic, and its resulting changes in consumer behavior and expectations, has also caused various traditional healthcare providers to evaluate and pursue telehealth options that can be paired with their in-person capabilities. Also, telehealth awareness, acceptance, and usage have been positively impacted by the COVID-19 pandemic, leading to increased consumer acceptance of virtual care. Thus, the pandemic led to an increase in the utilization of telehealth services, which is anticipated to boost the nutrigenomics market in the post-pandemic period.

Some of the companies operating in the cybersecurity in banking market are Ancestry, Nutrigenomix, 23andMe Inc., DNAfit, GX Sciences Inc., Xcode Life, Koninklijke DSM N.V. (Royal DSM), BASF SE, Danone S.A., and The Gene Box.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the nutrigenomics market analysis from 2022 to 2032 to identify the prevailing nutrigenomics market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the nutrigenomics market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global nutrigenomics market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Consumer Buying Behavior Analysis
  • End user preferences and pain points
  • Investment Opportunities
  • Upcoming/New Entrant by Regions
  • Technology Trend Analysis
  • Go To Market Strategy
  • Market share analysis of players by products/segments
  • Pain Point Analysis
  • Regulatory Guidelines
  • Strategic Recommedations
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Criss-cross segment analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Market share analysis of players at global/region/country level
  • SWOT Analysis

Key Market Segments

By Product Type

  • Reagents and Kits
  • Services

By Applications

  • Diabetes
  • Cardiovascular Diseases
  • Cancer Research
  • Obesity

By End User

  • Online Platforms
  • Hospitals and Clinics
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • UAE
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Cura Integrative Medicine
    • Holistic Health
    • Metagenics, Inc.
    • GX Sciences Inc.
    • The Gene Box
    • Nutrigenomix Inc.
    • Xcode Life
    • DNA Life
    • Interleukin Genetics
    • Genova Diagnostics

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
  • 3.4. Market dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities
  • 3.5. Market Share Analysis
  • 3.6. Brand Share Analysis
  • 3.7. Value Chain Analysis
  • 3.8. Regulatory Guidelines
  • 3.9. Key Regulation Analysis

CHAPTER 4: NUTRIGENOMICS MARKET, BY PRODUCT TYPE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Reagents and Kits
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Services
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country

CHAPTER 5: NUTRIGENOMICS MARKET, BY APPLICATIONS

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Obesity
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Diabetes
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Cardiovascular Diseases
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country
  • 5.5. Cancer Research
    • 5.5.1. Key market trends, growth factors and opportunities
    • 5.5.2. Market size and forecast, by region
    • 5.5.3. Market share analysis by country

CHAPTER 6: NUTRIGENOMICS MARKET, BY END USER

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Online Platforms
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Hospitals and Clinics
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Others
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country

CHAPTER 7: NUTRIGENOMICS MARKET, BY REGION

  • 7.1. Overview
    • 7.1.1. Market size and forecast By Region
  • 7.2. North America
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by Product Type
    • 7.2.3. Market size and forecast, by Applications
    • 7.2.4. Market size and forecast, by End User
    • 7.2.5. Market size and forecast, by country
      • 7.2.5.1. U.S.
      • 7.2.5.1.1. Market size and forecast, by Product Type
      • 7.2.5.1.2. Market size and forecast, by Applications
      • 7.2.5.1.3. Market size and forecast, by End User
      • 7.2.5.2. Canada
      • 7.2.5.2.1. Market size and forecast, by Product Type
      • 7.2.5.2.2. Market size and forecast, by Applications
      • 7.2.5.2.3. Market size and forecast, by End User
      • 7.2.5.3. Mexico
      • 7.2.5.3.1. Market size and forecast, by Product Type
      • 7.2.5.3.2. Market size and forecast, by Applications
      • 7.2.5.3.3. Market size and forecast, by End User
  • 7.3. Europe
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by Product Type
    • 7.3.3. Market size and forecast, by Applications
    • 7.3.4. Market size and forecast, by End User
    • 7.3.5. Market size and forecast, by country
      • 7.3.5.1. Germany
      • 7.3.5.1.1. Market size and forecast, by Product Type
      • 7.3.5.1.2. Market size and forecast, by Applications
      • 7.3.5.1.3. Market size and forecast, by End User
      • 7.3.5.2. UK
      • 7.3.5.2.1. Market size and forecast, by Product Type
      • 7.3.5.2.2. Market size and forecast, by Applications
      • 7.3.5.2.3. Market size and forecast, by End User
      • 7.3.5.3. France
      • 7.3.5.3.1. Market size and forecast, by Product Type
      • 7.3.5.3.2. Market size and forecast, by Applications
      • 7.3.5.3.3. Market size and forecast, by End User
      • 7.3.5.4. Spain
      • 7.3.5.4.1. Market size and forecast, by Product Type
      • 7.3.5.4.2. Market size and forecast, by Applications
      • 7.3.5.4.3. Market size and forecast, by End User
      • 7.3.5.5. Italy
      • 7.3.5.5.1. Market size and forecast, by Product Type
      • 7.3.5.5.2. Market size and forecast, by Applications
      • 7.3.5.5.3. Market size and forecast, by End User
      • 7.3.5.6. Rest of Europe
      • 7.3.5.6.1. Market size and forecast, by Product Type
      • 7.3.5.6.2. Market size and forecast, by Applications
      • 7.3.5.6.3. Market size and forecast, by End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key market trends, growth factors and opportunities
    • 7.4.2. Market size and forecast, by Product Type
    • 7.4.3. Market size and forecast, by Applications
    • 7.4.4. Market size and forecast, by End User
    • 7.4.5. Market size and forecast, by country
      • 7.4.5.1. China
      • 7.4.5.1.1. Market size and forecast, by Product Type
      • 7.4.5.1.2. Market size and forecast, by Applications
      • 7.4.5.1.3. Market size and forecast, by End User
      • 7.4.5.2. Japan
      • 7.4.5.2.1. Market size and forecast, by Product Type
      • 7.4.5.2.2. Market size and forecast, by Applications
      • 7.4.5.2.3. Market size and forecast, by End User
      • 7.4.5.3. India
      • 7.4.5.3.1. Market size and forecast, by Product Type
      • 7.4.5.3.2. Market size and forecast, by Applications
      • 7.4.5.3.3. Market size and forecast, by End User
      • 7.4.5.4. South Korea
      • 7.4.5.4.1. Market size and forecast, by Product Type
      • 7.4.5.4.2. Market size and forecast, by Applications
      • 7.4.5.4.3. Market size and forecast, by End User
      • 7.4.5.5. Australia
      • 7.4.5.5.1. Market size and forecast, by Product Type
      • 7.4.5.5.2. Market size and forecast, by Applications
      • 7.4.5.5.3. Market size and forecast, by End User
      • 7.4.5.6. Rest of Asia-Pacific
      • 7.4.5.6.1. Market size and forecast, by Product Type
      • 7.4.5.6.2. Market size and forecast, by Applications
      • 7.4.5.6.3. Market size and forecast, by End User
  • 7.5. LAMEA
    • 7.5.1. Key market trends, growth factors and opportunities
    • 7.5.2. Market size and forecast, by Product Type
    • 7.5.3. Market size and forecast, by Applications
    • 7.5.4. Market size and forecast, by End User
    • 7.5.5. Market size and forecast, by country
      • 7.5.5.1. Brazil
      • 7.5.5.1.1. Market size and forecast, by Product Type
      • 7.5.5.1.2. Market size and forecast, by Applications
      • 7.5.5.1.3. Market size and forecast, by End User
      • 7.5.5.2. UAE
      • 7.5.5.2.1. Market size and forecast, by Product Type
      • 7.5.5.2.2. Market size and forecast, by Applications
      • 7.5.5.2.3. Market size and forecast, by End User
      • 7.5.5.3. Saudi Arabia
      • 7.5.5.3.1. Market size and forecast, by Product Type
      • 7.5.5.3.2. Market size and forecast, by Applications
      • 7.5.5.3.3. Market size and forecast, by End User
      • 7.5.5.4. South Africa
      • 7.5.5.4.1. Market size and forecast, by Product Type
      • 7.5.5.4.2. Market size and forecast, by Applications
      • 7.5.5.4.3. Market size and forecast, by End User
      • 7.5.5.5. Rest of LAMEA
      • 7.5.5.5.1. Market size and forecast, by Product Type
      • 7.5.5.5.2. Market size and forecast, by Applications
      • 7.5.5.5.3. Market size and forecast, by End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product mapping of top 10 player
  • 8.4. Competitive dashboard
  • 8.5. Competitive heatmap
  • 8.6. Top player positioning, 2022

CHAPTER 9: COMPANY PROFILES

  • 9.1. Cura Integrative Medicine
    • 9.1.1. Company overview
    • 9.1.2. Key executives
    • 9.1.3. Company snapshot
  • 9.2. Holistic Health
    • 9.2.1. Company overview
    • 9.2.2. Key executives
    • 9.2.3. Company snapshot
  • 9.3. Metagenics, Inc.
    • 9.3.1. Company overview
    • 9.3.2. Key executives
    • 9.3.3. Company snapshot
  • 9.4. GX Sciences Inc.
    • 9.4.1. Company overview
    • 9.4.2. Key executives
    • 9.4.3. Company snapshot
  • 9.5. The Gene Box
    • 9.5.1. Company overview
    • 9.5.2. Key executives
    • 9.5.3. Company snapshot
  • 9.6. Nutrigenomix Inc.
    • 9.6.1. Company overview
    • 9.6.2. Key executives
    • 9.6.3. Company snapshot
  • 9.7. Xcode Life
    • 9.7.1. Company overview
    • 9.7.2. Key executives
    • 9.7.3. Company snapshot
  • 9.8. DNA Life
    • 9.8.1. Company overview
    • 9.8.2. Key executives
    • 9.8.3. Company snapshot
  • 9.9. Interleukin Genetics
    • 9.9.1. Company overview
    • 9.9.2. Key executives
    • 9.9.3. Company snapshot
  • 9.10. Genova Diagnostics
    • 9.10.1. Company overview
    • 9.10.2. Key executives
    • 9.10.3. Company snapshot